Penn researchers report long-term leukemia remissions in first personalized cell therapy trial

Eight of 14 patients in the first trial of the University of Pennsylvania’s personalized cellular therapy for chronic lymphocytic leukemia (CLL) responded to the therapy, with some complete… Source link